ResMed Inc. — Key Metrics
2 years of history · ending 2025-06-30 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$10
Book Value Per Share
$41
Free Cash Flow Per Share
$11
Cash Per Share
$8
Revenue Per Share
$35
OCF Per Share
$12
Return on Equity
25.9%
Return on Assets
18.6%
Return on Invested Capital
23.1%
Debt to Equity
0.11
Current Ratio
3.44
Quick Ratio
2.53
Asset Turnover
0.68
Days Sales Outstanding
66.63
Days Payables Outstanding
48.55
Days Inventory On Hand
161.91
Cash Conversion Cycle
180.00
R&D / Revenue
6.4%
SBC / Revenue
1.8%
Capex / Revenue
1.7%
Working Capital
$2.49B
Net Current Asset Value
$1.30B
Invested Capital
$6.63B
OCF / Net Income
1.25
FCF / Net Income
1.19
Accruals Ratio (Sloan)
-4.3%
Net Debt
$-541M
Net Debt / EBITDA
-0.29
Interest Coverage
409.67
Cash Coverage
425.76
Dividend Coverage
5.63
Capex Coverage
19.49
Tangible Common Equity
$2.46B
TCE / Total Assets
30.0%
Goodwill / Total Assets
37.3%
NOPAT
$1.41B
Cash ROIC
27.3%
WC / Revenue
48.3%
Capex / D&A
0.45
Reinvestment Rate
1.8%
Total Payout Ratio
43.6%
Asset Growth vs Revenue Growth
9.1%
Revenue 5Y CAGR
11.7%
EPS 5Y CAGR
17.6%
FCF 5Y CAGR
18.6%
EBITDA 5Y CAGR
14.3%
Book Value 5Y CAGR
19.0%
Stock Price (FY-end)
$256
Market Cap
$37.76B
P/E Ratio
26.96
P/S Ratio
7.34
P/B Ratio
6.33
P/TB Ratio
15.37
P/OCF Ratio
21.56
P/FCF Ratio
22.72
Enterprise Value
$37.22B
EV / EBITDA
19.76
EV / Sales
7.23
EV / FCF
22.40
FCF Yield
4.4%
Dividend Yield
0.8%
Shareholder Yield
1.4%
Buyback Yield
0.8%
R&D Yield
0.9%
Capex Yield
0.2%
Dividend Per Share
$2
DPS YoY Growth
10.3%
Operating Leverage
2.81
Graham Number
$93
Shares Variation (YoY)
-0.1%
Beta (5Y)
0.83
Cost of Equity
8.6%
Cost of Debt (after tax)
0.5%
WACC
—
ROIC - WACC Spread
—
52W High
$256
52W Low
$184
Trailing Return 1Y
39.6%
Trailing Return 5Y
47.9%
F-Score (Piotroski)
8.00
M-Score (Beneish)
-2.58
Z-Score (Altman)
12.98
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.